Literature DB >> 21814457

Research With Cognitively Impaired Participants.

Ukamaka M Oruche.   

Abstract

Illnesses that cause cognitive impairment are a considerable health problem in the United States. These include Alzheimer's disease, Huntington's chorea, cerebrovascular disease, psychiatric disorders, chronic alcoholism, and AIDS dementia complex. Illness associated with cognitive impairment may cause great suffering to the affected patients and their families. Research involving individuals who may be at risk for or have cognitive impairment is necessary to improve our understanding of these illnesses. For example, this may occur during efforts to develop effective therapies to treat them. However, research with participants who have cognitive impairment presents additional ethical concerns because they may be vulnerable to coercion. Therefore, nurse researchers must not only understand the principles of informed consent (i.e., autonomy, beneficence, nonmaleficence, and justice), but also the additional safeguards provided in the common rule to protect cognitively impaired participants in research. These safeguards include advanced informed consent, legal representative, and assent. Gaps exist in federal regulations related to adhering to these safeguards such as how to assess for decision-making capacity and variations on who can be a legal representative. The nurse researchers have potential roles as educators and advocates in research involving participants with cognitive impairment.

Entities:  

Year:  2009        PMID: 21814457      PMCID: PMC3148014          DOI: 10.1891/1073-7472.13.3.89

Source DB:  PubMed          Journal:  J Nurs Law        ISSN: 1073-7472


  14 in total

Review 1.  Ethical considerations for research in critically ill patients.

Authors:  Luca M Bigatello; Edward George; William E Hurford
Journal:  Crit Care Med       Date:  2003-03       Impact factor: 7.598

2.  Research involving cognitively impaired adults.

Authors:  Jason H T Karlawish
Journal:  N Engl J Med       Date:  2003-04-03       Impact factor: 91.245

3.  Waste not, want not: cognitive impairment should not preclude research participation.

Authors:  Gavin W Hougham
Journal:  Am J Bioeth       Date:  2005       Impact factor: 11.229

4.  The inability to consent in critical care research: emergency or impairment of cognitive function?

Authors:  François Lemaire
Journal:  Intensive Care Med       Date:  2006-09-21       Impact factor: 17.440

Review 5.  Conducting stroke research with an exception from the requirement for informed consent.

Authors:  Brian T Bateman; Philip M Meyers; H Christian Schumacher; Sundeep Mangla; John Pile-Spellman
Journal:  Stroke       Date:  2003-03-27       Impact factor: 7.914

6.  Enhancing informed consent for research and treatment.

Authors:  L B Dunn; D V Jeste
Journal:  Neuropsychopharmacology       Date:  2001-06       Impact factor: 7.853

7.  Research consent for cognitively impaired adults: recommendations for institutional review boards and investigators.

Authors: 
Journal:  Alzheimer Dis Assoc Disord       Date:  2004 Jul-Sep       Impact factor: 2.703

8.  Capacity to provide informed consent for participation in schizophrenia and HIV research.

Authors:  David J Moser; Susan K Schultz; Stephan Arndt; Michelle L Benjamin; Frank W Fleming; Colleen S Brems; Jane S Paulsen; Paul S Appelbaum; Nancy C Andreasen
Journal:  Am J Psychiatry       Date:  2002-07       Impact factor: 18.112

9.  Assessment of therapeutic misconception in older schizophrenia patients with a brief instrument.

Authors:  Laura B Dunn; Barton W Palmer; Monique Keehan; Dilip V Jeste; Paul S Appelbaum
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

10.  Durable power of attorney and informed consent with Alzheimer's disease patients: a clinical study.

Authors:  R Dukoff; T Sunderland
Journal:  Am J Psychiatry       Date:  1997-08       Impact factor: 18.112

View more
  1 in total

1.  Procedural Framework to Facilitate Hospital-Based Informed Consent for Dementia Research.

Authors:  Timothy R Holden; Sarah Keller; Alice Kim; Michael Gehring; Emily Schmitz; Carol Hermann; Andrea Gilmore-Bykovskyi; Amy J H Kind
Journal:  J Am Geriatr Soc       Date:  2018-09-24       Impact factor: 5.562

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.